These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 31781020)

  • 21. The interplay between gut microbiota and the brain-gut axis in Parkinson's disease treatment.
    Jia X; Wang Q; Liu M; Ding JY
    Front Neurol; 2024; 15():1415463. PubMed ID: 38867886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis.
    Shen T; Yue Y; He T; Huang C; Qu B; Lv W; Lai HY
    Front Aging Neurosci; 2021; 13():636545. PubMed ID: 33643026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiota and Neurologic Diseases and Injuries.
    Tyler Patterson T; Grandhi R
    Adv Exp Med Biol; 2020; 1238():73-91. PubMed ID: 32323181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nutritional approach to microbiota in Parkinson's disease.
    Uyar GÖ; Yildiran H
    Biosci Microbiota Food Health; 2019; 38(4):115-127. PubMed ID: 31763115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut-brain axis: gut dysbiosis and psychiatric disorders in Alzheimer's and Parkinson's disease.
    Denman CR; Park SM; Jo J
    Front Neurosci; 2023; 17():1268419. PubMed ID: 38075261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease.
    Fitzgerald E; Murphy S; Martinson HA
    Front Neurosci; 2019; 13():369. PubMed ID: 31068777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotics for Parkinson's Disease.
    Gazerani P
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.
    Quigley EMM
    Curr Neurol Neurosci Rep; 2017 Oct; 17(12):94. PubMed ID: 29039142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism.
    Wang W; Jiang S; Xu C; Tang L; Liang Y; Zhao Y; Zhu G
    Front Aging Neurosci; 2022; 14():976316. PubMed ID: 36408101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
    Spielman LJ; Gibson DL; Klegeris A
    Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.
    Perez-Pardo P; Kliest T; Dodiya HB; Broersen LM; Garssen J; Keshavarzian A; Kraneveld AD
    Eur J Pharmacol; 2017 Dec; 817():86-95. PubMed ID: 28549787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance.
    Tiwari P; Dwivedi R; Bansal M; Tripathi M; Dada R
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gut and Nonmotor Symptoms in Parkinson's Disease.
    Klingelhoefer L; Reichmann H
    Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gut-Brain Axis in Alzheimer's and Parkinson's Diseases: The Catalytic Role of Mitochondria.
    Candeias E; Pereira-Santos AR; Empadinhas N; Cardoso SM; Esteves ARF
    J Alzheimers Dis; 2024 Jun; ():. PubMed ID: 38875045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapies for Parkinson's disease and the gut microbiome: evidence for bidirectional connection.
    Hey G; Nair N; Klann E; Gurrala A; Safarpour D; Mai V; Ramirez-Zamora A; Vedam-Mai V
    Front Aging Neurosci; 2023; 15():1151850. PubMed ID: 37323145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.
    Chiang HL; Lin CH
    J Mov Disord; 2019 May; 12(2):67-83. PubMed ID: 31158941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invited Review: From nose to gut - the role of the microbiome in neurological disease.
    Bell JS; Spencer JI; Yates RL; Yee SA; Jacobs BM; DeLuca GC
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):195-215. PubMed ID: 30298527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications.
    Jain A; Madkan S; Patil P
    Cureus; 2023 Oct; 15(10):e47861. PubMed ID: 38022117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.